๐ Novo Nordisk Jumps as UK Approves Wegovy and Company Launches New Share Buyback
Novo Nordisk shares surged today after UK regulators officially approved Wegovy (semaglutide) for obesity treatment โ adding a major new market to the drug already dominant in the US and EU. The company paired the regulatory win with a fresh share buyback announcement, giving investors a double catalyst. Comcast also moved on a British broadcaster acquisition just a week after announcing its NBCUniversal spin-off plans. Not financial advice. Is the GLP-1 drug trade still the most compelling macro theme of 2026?
โก 4 buzzing
102 views
๐ 0 subscribed